Buggy Y, Maguire T M, McGreal G, McDermott E, Hill A D K, O'Higgins N, Duffy M J
Department of Surgery, University College Dublin, St Vincent's University Hospital, Dublin 4, Ireland.
Br J Cancer. 2004 Oct 4;91(7):1308-15. doi: 10.1038/sj.bjc.6602128.
The Ets family of transcription factors regulate expression of multiple genes involved in tumour progression. The aim of this study was to investigate the expression of Ets-1 in a large panel of human breast cancers and relate its levels to the parameters of tumour progression and metastasis. Using RT-PCR, Ets-1 mRNA was detected in 30 out of 42 (71%) fibroadenomas and 131 out of 179 (73%) primary breast carcinomas. Similarly, levels of Ets-1 mRNA were not significantly different in fibroadenomas and primary breast carcinomas. Using Western blotting, four forms of the Ets-1 protein were detected, that is, p33, p42, p51 and p52. Levels of both p51 and p52 but not p33 and p42 were present at significantly higher levels in the carcinomas compared to the fibroadenomas (for p51, P<0.007; for p52, P<0.02; Mann-Whitney U-test). Levels of p52, p51 and p33 correlated significantly with uPA protein levels (P<0.01), while only levels of p52 correlated significantly with HER-2/neu protein levels (P<0.01). Using immunohistochemistry, Ets-1 was found predominantly in tumour cells, but was also detected in some stromal cells surrounding tumour islands. We conclude that, while at the mRNA level, Ets-1 was found at similar levels in fibroadenomas and primary breast carcinomas, higher protein levels were detected in the cancers compared to the benign specimens. Since p52, p51 and p33 correlate with uPA levels, these forms of Ets-1 may play a role in breast cancer metastasis.
Ets转录因子家族调控多个参与肿瘤进展的基因的表达。本研究的目的是调查Ets-1在大量人类乳腺癌中的表达情况,并将其水平与肿瘤进展和转移参数相关联。使用逆转录聚合酶链反应(RT-PCR),在42例纤维腺瘤中的30例(71%)以及179例原发性乳腺癌中的131例(73%)检测到Ets-1信使核糖核酸(mRNA)。同样,纤维腺瘤和原发性乳腺癌中Ets-1 mRNA的水平没有显著差异。使用蛋白质免疫印迹法,检测到Ets-1蛋白的四种形式,即p33、p42、p51和p52。与纤维腺瘤相比,p51和p52而非p33和p42在癌组织中的水平显著更高(p51,P<0.007;p52,P<0.02;曼-惠特尼U检验)。p52、p51和p33的水平与尿激酶型纤溶酶原激活物(uPA)蛋白水平显著相关(P<0.01),而只有p52的水平与人类表皮生长因子受体2/神经(HER-2/neu)蛋白水平显著相关(P<0.01)。使用免疫组织化学法,发现Ets-1主要存在于肿瘤细胞中,但在肿瘤岛周围的一些基质细胞中也能检测到。我们得出结论,虽然在mRNA水平上,纤维腺瘤和原发性乳腺癌中Ets-1的水平相似,但与良性标本相比,癌组织中检测到更高的蛋白水平。由于p52、p51和p33与uPA水平相关,这些形式的Ets-1可能在乳腺癌转移中起作用。